Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Drug Alcohol Rev ; 36(5): 626-632, 2017 09.
Article in English | MEDLINE | ID: mdl-27349485

ABSTRACT

INTRODUCTION AND AIMS: Information on high-risk drug use in Turkey, particularly at the regional level, is lacking. The present analysis aims at estimating high-risk cannabis use (HRCU) and high-risk opiate use (HROU) in the cities of Ankara, Istanbul and Izmir. DESIGN AND METHODS: Capture-recapture and multiplier methods were applied based on treatment and police data stratified by age and gender in the years 2009 and 2010. Case definitions refer to ICD-10 cannabis (F.12) and opiate (F.11) disorder diagnoses from outpatient and inpatient treatment records and illegal possession of these drugs as recorded by the police. RESULTS: High-risk cannabis use was estimated at 28 500 (8.5 per 1000; 95% confidence interval 7.3-10.3) and 33 400 (11.9 per 1000; 95% confidence interval 10.7-13.5) in Ankara and Izmir, respectively. Using multipliers based on capture-recapture estimates for Izmir, HRCU in Istanbul was estimated up to 166 000 (18.0 per 1000; range: 2.8-18.0). Capture-recapture estimates of HROU resulted in 4800 (1.4 per 1000; 95% confidence interval 0.9-1.9) in Ankara and multipliers based on these gave estimates up to 20 000 (2.2 per 1000; range: 0.9-2.2) in Istanbul. HROU in Izmir was not estimated due to the low absolute numbers of opiate users. DISCUSSION AND CONCLUSIONS: While HRCU prevalence in both Ankara and Izmir was considerably lower in comparison to an estimate for Berlin, the rate for Istanbul was only slightly lower. Compared with the majority of European cities, HROU in these three Turkish cities may be considered rather low. [Kraus L, Hay G, Richardson C, Yargic I, Ilhan N M, Ay P, Karasahin F, Pinarci M, Tuncoglu T, Piontek D, Schulte B Estimating high-risk cannabis and opiate use in Ankara, Istanbul and Izmir Drug Alcohol Rev 2016;00:000-000].


Subject(s)
Dangerous Behavior , Marijuana Smoking/epidemiology , Opioid-Related Disorders/epidemiology , Adolescent , Adult , Female , Humans , Male , Middle Aged , Turkey/epidemiology , Young Adult
2.
Turk Psikiyatri Derg ; 26(3): 172-80, 2015.
Article in Turkish | MEDLINE | ID: mdl-26364171

ABSTRACT

PURPOSE: Interpersonal relationship disorders in adults with Attention Deficit Hyperactivity Disorder (ADHD) can be associated with the impairment of non-verbal communication. The purpose of our study was to compare the emotion recognition, facial recognition and neuropsychological assessments of adult ADHD patients with those of healthy controls, and to thus determine the effect of neuropsychological data on the recognition of emotional expressions. METHODS: This study, which was based on a case-control model, was conducted with patients diagnosed with ADHD according to the DSM-IV-TR, being followed and monitored at the adult ADHD clinic of the Psychiatry Department of the Istanbul University Istanbul Medical Faculty Hospital. The study group consisted of 40 adults (27.5% female) between the ages of 20-65 (mean age 25.96 ± 6.07; education level: 15.02±2.34 years) diagnosed with ADHD, and 40 controls who were matched/similar with the study group with respect to age, gender, and education level. In the ADHD group, 14 (35%) of the patients had concomitant diseases. Pictures of Facial Affect, the Benton Face Recognition Test, and the Continuous Performance Test were used to respectively evaluate emotion recognition, facial recognition, and attention deficit and impulsivity of the patients. RESULTS: It was determined that, in comparison to the control group, the ADHD group made more mistakes in recognizing all types of emotional expressions and neutral expressions. The ADHD group also demonstrated more cognitive mistakes. Facial recognition was similar in both groups. It was determined that impulsivity had a significant effect on facial recognition. CONCLUSION: The social relationship disorders observed in ADHD can be affected by emotion recognition processes. In future studies, it may be possible to investigate the effects that early psychopharmacological and psychotherapeutic interventions administered for the main symptoms of ADHD have on the impairment of emotion recognition.


Subject(s)
Attention Deficit Disorder with Hyperactivity/psychology , Emotions , Facial Recognition , Impulsive Behavior , Adult , Case-Control Studies , Female , Humans , Male
3.
J Trauma Dissociation ; 15(1): 24-34, 2014.
Article in English | MEDLINE | ID: mdl-24377970

ABSTRACT

A total of 34 consecutive patients with dissociative identity disorder or dissociative disorder not otherwise specified were evaluated using the Turkish version of the Structured Clinical Interview for DSM-IV Dissociative Disorders (SCID-D). They were compared with a matched control group composed of 34 patients who had a nondissociative psychiatric disorder. Interrater reliability was evaluated by 3 clinicians who assessed videotaped interviews conducted with 5 dissociative and 5 nondissociative patients. All subjects who were previously diagnosed by clinicians as having a dissociative disorder were identified as positive, and all subjects who were previously diagnosed as not having a dissociative disorder were identified as negative. The scores of the main symptom clusters and the total score of the SCID-D differentiated dissociative patients from the nondissociative group. There were strong correlations between the SCID-D and the Dissociative Experiences Scale total and subscale scores. These results are promising for the validity and reliability of the Turkish version of the SCID-D. However, as the present study was conducted on a predominantly female sample with very severe dissociation, these findings should not be generalized to male patients, to dissociative disorders other than dissociative identity disorder, or to broader clinical or nonclinical populations.


Subject(s)
Cross-Cultural Comparison , Diagnostic and Statistical Manual of Mental Disorders , Dissociative Disorders/diagnosis , Dissociative Disorders/psychology , Interview, Psychological , Adult , Female , Humans , Male , Observer Variation , Psychometrics/statistics & numerical data , Reference Values , Reproducibility of Results , Translating , Turkey , Young Adult
4.
Noro Psikiyatr Ars ; 51(2): 97-102, 2014 Jun.
Article in English | MEDLINE | ID: mdl-28360607

ABSTRACT

INTRODUCTION: The aims of this study were to determine the frequency of adult attention deficit and hyperactivity disorder (ADHD) comorbidity in bipolar patients and to investigate the influence of this comorbidity on the clinical characteristics of bipolar disorder (BD). METHOD: A total of 135 patients with BD type I and II and BD not otherwise specified were included in this study. First, the Adult ADD/ADHD DSM-IV-Based Diagnostic Screening and Rating Scale (ADHD scale) was administered to all patients, and all of the patients were also interviewed for the diagnosis. Patients who were diagnosed as having ADHD comorbidity (n=23) on the basis of DSM-IV and those who were not diagnosed to have ADHD comorbidity (n=32) were compared in terms of sociodemographic and clinical correlates. RESULTS: Twenty-three of 135 patients (17%) were found to have ADHD comorbidity. In the ADHD comorbidity group, the level of education and the number of suicide attempts were higher (p=.011 and .043, respectively). Although not significant, subthreshold depressive symptoms in interepisodic periods, the lifetime history of antidepressant use and the total number of lifetime depressive episodes tended to be more frequent in bipolar disorder with ADHD comorbidity group than in the control group. CONCLUSION: Bipolar disorder has a frequent comorbidity with ADHD, and contrary to expectations, it might be related to the depressive aspect, rather than the manic aspect, of bipolar disorder. Early diagnosis of ADHD comorbidity in bipolar patients might help to prevent serious risk factors.

5.
Oral Surg Oral Med Oral Pathol Oral Radiol ; 114(5 Suppl): S132-9, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23063389

ABSTRACT

OBJECTIVE: The aim of this study was to compare anxiety and pain levels during anesthesia and efficacy of Quicksleeper intraosseous (IO) injection system, which delivers computer-controlled IO anesthesia and conventional inferior alveolar nerve block (IANB) in impacted mandibular third molars. STUDY DESIGN: Forty subjects with bilateral impacted mandibular third molars randomly received IO injection or conventional IANB at 2 successive appointments. The subjects received 1.8 mL 2% articaine. RESULTS: IO injection has many advantages, such as enabling painless anesthesia with less soft tissue numbness and quick onset of anesthesia as well as lingual and palatal anesthesia with single needle penetration. CONCLUSIONS: Although IO injection is a useful technique commonly used during various treatments in dentistry, the duration of injection takes longer than conventional techniques, there is a possibility of obstruction at the needle tip, and, the duration of the anesthetic effect is inadequate for prolonged surgical procedures.


Subject(s)
Anesthesia, Dental/methods , Anesthesia, Local/methods , Anesthetics, Local/therapeutic use , Anxiety/drug therapy , Carticaine/therapeutic use , Nerve Block/methods , Pain/drug therapy , Adult , Analysis of Variance , Female , Humans , Infusions, Intraosseous/instrumentation , Infusions, Intraosseous/methods , Injections/methods , Male , Mandible/surgery , Molar, Third/surgery , Pain Measurement , Statistics, Nonparametric , Tooth, Impacted/surgery , Treatment Outcome
6.
Subst Abus ; 33(2): 92-8, 2012.
Article in English | MEDLINE | ID: mdl-22489580

ABSTRACT

The purpose of this study is to determine if a significant relationship exists between the sociodemographics, substance use characteristics, criminal history, and completion of substance abuse treatment. In this study, 115 individuals being monitored for substance abuse treatment on probation at the Probation and Help Center under the Republic of Turkey's Ministry of Justice's Chief Public Prosecutor's Office of Istanbul were included successively between the dates of April 2008 and April 2009. During a 24-week follow-up, individuals whose urine analyses were clean 6 times consecutively were considered to have completed the treatment successfully. To determine the effect of sociodemographic factors and substance use characteristics on treatment completion, a semistructured sociodemographic data survey was used. Also, the participants' criminal records were examined. A total of 115 people participated in the study. One hundred ten (95.7%) of them were male. Sixty-eight (59.1%) of the participants had completed treatment. Age group, education level, age of onset for substance use, number of substances used, employment status, and criminal records showed a significant difference between treatment completers and noncompleters. When a logistic regression analysis was done, only number of substances used and criminal record (other than drug possession) were significantly different for the 2 groups. The current treatment program for polysubstance users and individuals with a criminal record is insufficient. It is necessary that treatment systems be developed so they can be beneficial for these types of patients.


Subject(s)
Criminals , Substance-Related Disorders/rehabilitation , Adult , Criminals/psychology , Female , Follow-Up Studies , Humans , Logistic Models , Male , Socioeconomic Factors , Substance Abuse Detection , Substance-Related Disorders/therapy , Treatment Outcome , Turkey , Urinalysis
8.
Subst Abus ; 32(3): 168-9, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21660879

ABSTRACT

Quetiapine is a new-generation antipsychotic medication approved in the treatment of schizophrenia, bipolar disorder, and related disorders. There are reports about the abuse and possible dependence of quetiapine. We present the first case of definite quetiapine dependence. This is a 37-year-old male who applied to the addiction unit because he could not control quetiapine use. He had a history of alcohol and benzodiazepine dependence as well as cannabis abuse. He reported to have a rush on quetiapine and suffered from its withdrawal when he tried to wean off the medication. This case and similar other suggest that while quetiapine may be beneficial in the treatment of some patients with addictive disorders, we should be cautious when using quetiapine to treat patients with drug or alcohol dependence.


Subject(s)
Antipsychotic Agents/adverse effects , Dibenzothiazepines/adverse effects , Substance Withdrawal Syndrome/diagnosis , Substance-Related Disorders/diagnosis , Adult , Humans , Male , Quetiapine Fumarate
9.
Am J Addict ; 13(2): 151-62, 2004.
Article in English | MEDLINE | ID: mdl-15204666

ABSTRACT

In this study, we sought to evaluate a modification of the Michigan Alcohol Screening Test designed to include problems associated with other drug abuse/dependence besides alcohol. Scores of the lifetime Michigan Assessment-Screening Test/Alcohol-Drug (MAST/AD) were compared to other lifetime measures of substance abuse and dependence and to psychiatric scales reflecting current or recent symptoms. Two university medical centers with alcohol-drug programs located within departments of psychiatry hosted 520 patients with alcohol-drug-related diagnoses. Patients completed their own MAST/AD using a paper-and-pencil format. Based on interviews with the patient, a research associate rated the patients' substance-related problems on the Minnesota Substance Abuse Problem Scale (M-SAPS) and obtained information on lifetime treatment for substance abuse. An addictions psychiatrist determined abuse or dependence and made a current diagnosis of alcohol abuse/dependence only, drug abuse/dependence only, and alcohol plus drug abuse/dependence. The MAST/AD was highly correlated with the M-SAPS and several other measures of substance abuse morbidity. Patients with alcohol-only and drug-only diagnoses did not differ from one another on the MAST/AD, although both groups had lower scores than those with alcohol plus drug diagnoses. Current psychosocial morbidity as assessed by the patient and the psychiatrist was associated with the MAST/AD, although less strongly than with lifetime substance abuse measures. The lifetime MAST/AD demonstrates reliability as a severity measure for alcohol and/or drug abuse. With minor modification, this standard measure can be expanded from alcohol diagnoses to all substance diagnoses. This study in a clinical population did not demonstrate its utility as a screening instrument; additional work is needed to reveal its utility for this purpose.


Subject(s)
Mass Screening/methods , Substance-Related Disorders/epidemiology , Surveys and Questionnaires , Adult , Alcoholism/diagnosis , Alcoholism/epidemiology , Demography , Female , Humans , Male , Psychology , Reproducibility of Results , Substance-Related Disorders/diagnosis
10.
Quintessence Int ; 35(4): 317-20, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15119719

ABSTRACT

Schizophrenia is a brain disease that manifests itself with multiple signs and symptoms involving thought, perception, emotion, and behavior. Despite the fact that these manifestations combine in various ways to create considerable diversity among patients, the cumulative effect of the illness is always severe and usually long lasting. Schizophrenia is diagnosed in the presence of certain positive and negative psychotic symptoms, as well as psychologic and cognitive deterioration. In addition to history, medical and psychiatric examinations are used to rule out other possible diagnoses. Schizophrenia is not a rare disorder, and it affects approximately 1% of the general population. Many of these individuals require several hospitalizations, and the financial cost of schizophrenia is substantial. In this article, clinical features of schizophrenia are reviewed, and the important consequences from the perspective of dental practitioners are highlighted.


Subject(s)
Dental Care for Disabled , Schizophrenia , Adolescent , Adult , Female , Humans , Male , Schizophrenia/drug therapy , Schizophrenia/physiopathology , Schizophrenic Psychology
SELECTION OF CITATIONS
SEARCH DETAIL